Showing results 1 to 20 of 31
next >
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Aptamer-based inhibitor of sclerostin for Osteoporosis Therapy Proceeding/Conference:Research Postgraduate Symposium, RPS 2009 | 2009 | 129 | ||
Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2 Proceeding/Conference:Hong Kong Inter-University Biochemistry Postgraduate Symposium | 2010 | 120 | ||
Aptamer-mediated inhibition of mycobacterium tuberculosis polyphosphate kinase 2 Journal:Biochemistry | 2011 | 197 | ||
Aptamer-mediated Inhibition of Mycobacterium tuberculosis Polyphosphate Kinase 2 Proceeding/Conference:Hong Kong Chemical Biology Symposium | 2009 | 104 | ||
Aptamers against polyphosphate kinase 2 (PPK2) from mycobacterium tuberculosis as a potential approach of novel anti-tuberculosis therapy Proceeding/Conference:Croucher Foundation ASI Conference on Structure-Based Screening & Design of Ligands for Protein Targets | 2009 | 116 | ||
Bismuth complexes inhibit the SARS coronavirus Journal:Angewandte Chemie - International Edition | 2007 | 562 | ||
Chemical biology Book:Kirk-Othmer Encyclopedia of Chemical Technology | 2010 | 142 | ||
Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. Journal:Chembiochem : a European journal of chemical biology | 2008 | 176 | ||
Dissecting the mechanism of binding between polyphosphate and polyphosphate kinase 2 Proceeding/Conference:Hong Kong Inter-University Postgraduate Symposium | 2012 | 140 | ||
Dissecting the mechanism of how mycobacterium tuberculosis polyphosphate kinase 2 binds to polyphosphate Proceeding/Conference:Annual Meeting of the European Molecular Biology Organisation, EMBO 2013 | 2013 | 29 | ||
DNA aptamers binding H5N1 virus nucleoprotein showed antiviral effects Proceeding/Conference:Keystone Symposia on Molecular and Cellular Biology 2011: Evolving Approaches to Early-Stage Drug Discovery | 2011 | 131 | ||
Effect of inorganic polyphosphate on higher eukaryotic cells Proceeding/Conference:Research Postgraduate Symposium, RPS 2009 | 2009 | 88 | ||
G-quadruplex aptamers inhibit sclerostin for osteoporosis therapy Proceeding/Conference:Croucher Foundation ASI Conference on Structure-Based Screening & Design of Ligands for Protein Targets | 2009 | 113 | ||
G-quadruplex DNA aptamers and their ligands: Structure, function and application Journal:Current Pharmaceutical Design | 2012 | 180 | ||
Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling Journal:Biochemical Journal | 2011 | 207 | ||
In vitro aptamer selection against the SARS Coronavirus Helicase Proceeding/Conference:Annual Symposium of the Hong Kong Proteomics Society, HKPS 2007 | 2007 | 86 | ||
In vitro aptamer selection against the SARS coronavirus helicase and their intracellular delivery Proceeding/Conference:Annual Meeting of the Oligonucleotide Therapeutic Society, OTS 2007 | 2007 | 86 | ||
In vitro selection of DNA aptamers binding H5N1 Virus nucleoprotein Proceeding/Conference:Research Postgraduate Symposium, RPS 2008 | 2008 | 102 | ||
Inhibiting sclerostin with a nucleic acid aptamer as a new approach to osteoporosis therapy Proceeding/Conference:Johnson & Johnson Asia Outstanding Graduate Thesis Award in Bio-tech | 2011 | 106 | ||
Inorganic polyphosphate triggers interleukin 11 production in osteoblasts cell signalling Proceeding/Conference:The FEBS Journal | 2013 | 56 |